Focus Healthcare Technologies
From its Healthcare Technology funds GHC I and GHC II, Gilde Healthcare Partners invests in private companies across the healthcare sector. The Fund focuses on early stage companies engaged in the development of novel therapeutics, diagnostics and medical devices. Gilde focuses on European and US companies.Today’s start-up companies are well positioned to capture value and build on this reputation. This is evidenced by the commercial success of new therapies and increasing demand from the pharmaceutical industry for new drug candidates to fuel their pipelines and anticipate on drug patent expirations. This leads to an increase in the number of licensing and acquisition transactions undertaken, and in turn, growth in the size of the deals themselves.
Europe has a historically strong science base and is a major source of innovative companies developing drugs, diagnostics and medical devices for the global market.
